Christopher Cabell

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
San Diego, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Mark Iwicki, attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Christopher Cabell

Form 4 holding CMO & Head of R&D

Zura Bio Ltd

Security class
Class A Ordinary Shares
Shares / value
162,060
Estimated value
$648,240
Report date
18 May 2023
Price
$4.00
Ownership
Direct
Form 4 holding Director

Pulmatrix, Inc.

Security class
Stock Option (Right to Buy)
Shares / value
1,700
Estimated value
Report date
26 Jan 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Christopher Cabell

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .